Keywords
Laryngeal neoplasms
Epidemiology
Health systems
Neoplasms
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe the prevalence, clinicopathological characteristics and sociodemographic profile of patients with laryngeal cancer treated in a radiotherapy service. Methods: This is a cross-sectional study with a quantitative approach, carried out in a hospital in Pernambuco, a reference in radiotherapy treatment in the municipalities of the fourth regional health management, with the time frame from 2010 to 2020, the data were selected from medical records of patients diagnosed with laryngeal cancer and then collected information regarding tumor characteristics and sociodemographic variables Results: 194 medical records of patients diagnosed with laryngeal cancer were analyzed. The majority were male, with an average age of 64, brown, married, with incomplete primary education and farmers. The highest percentage was glottic tumors, consistent with the higher number of patients with vocal impairment, there was a higher number of diagnoses of squamous cell carcinoma (SCC) and patients from the Unified Health System (SUS), with regard to the proportion of cure of this neoplasm, the data represented a percentage of 22.2%. Final considerations: It is important to know the epidemiology and characteristics of laryngeal cancer. Through this, specific actions can be taken to minimize the incidence of this type of cancer.
References
BAIRD B, et al. Treatment of early-stage laryngeal cancer: a comparison of treatment options. Oral Oncol, 2018; 87: 8-16.
BARBOSA IR, et al. Desigualdades socioeconômicas e mortalidade por câncer: um estudo ecológico no Brasil. Revista Brasileira em Promoção da Saúde, 2016; 29: 350-356.
BARBOZA S, et al. Social inequality in incidence and mortality of malignant neoplasms of lip, oral cavity and pharynx: Is Costa Rica an international paradox?. Community Dent Oral Epidemiol, 2022; 50: 243-250.
BASARAN B e UNSALER S. Carcinoma da parede posterior da hipofaringe: tratamento cirúrgico com preservação da laringe. Brazilian Journal of Otorhinolaryngology. 2022; 88: 174-180.
BATISTA JFC, et al. Tendência temporal da mortalidade por câncer de laringe no Brasil e regiões, no período de 1980 a 2019. Revista de Ciências Médicas e Biológicas, 2019; 21: 31-39.
BECK AJCC, et al. Cost-Effectiveness of Surgery Versus Organ Preservation in Advanced Laryngeal Cancer. Laryngoscope. 2021; 131: 509–517.
BOTTAZZI B, et al. Aging, inflammation and cancer. Semin Immunol. 2018; 40: 74-82.
BRASIL. Lei nº 13.709, de 14 de agosto de 2018. Lei Geral de Proteção de Dados Pessoais (LGPD). L13709. Disponível em: https ://www.planalto.gov.br/ccivil_03/_ato2015-2018/2018/lei/l13709.htm Acessado em: 23 de abril de 2024.
BRASIL, Ministério da Saúde, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimativa 2023 a 2025: Pernambuco – estimativa de novos casos. Rio de Janeiro, 2022. Disponível em: https ://www.gov.br/inca/pt-br/assuntos/cancer/numeros/estimativa/estado-capital/pernambuco Acessado em: 11 de abril de 2024.
CAMPBELL G, et al. Advances in Organ Preservation for Laryngeal Cancer. Curr Treat Options Oncol. 2022; 23: 594-608.
CIOLOFAN MS, et al. Clinical, histological and immunohistochemical evaluation of larynx cancer. Curr Health Sci J. 2017; 43: 367–375.
CLIN B, et al. Head and neck cancer and asbestos exposure. Occup Environ Med. 2022; 79: 690-696.
COSTA SNL, et al. Incidence and mortality by larynx cancer in Central and South America. Rev Gaucha Enferm. 2021; 42: 1-11.
DENG Y, et al. Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study. Aging (Albany NY). 2020; 12: 2545-2583.
FERREIRA MC. Desigualdades sociais na incidência, mortalidade e sobrevida de câncer em mulheres em um município do Sudeste do Brasil. Cad Saude Publica. 2022; 38: 1-13.
FIGUEIREDO IC, et al. Profile and speech-language rehabilitation of patients with laryngeal cancer. Codas. 2019; 31: 1-8.
HAROUNIAN J, et al. Medications and the larynx. Curr Opin Otolaryngol Head Neck Surg. 2019; 27: 482-488.
HUTCHESON KA e LEWIN JS. Functional assessment and rehabilitation: how to maximize outcomes. Otolaryngol Clin North Am. 2013; 46: 657-670.
LEWIS JS, et al. Verrucous carcinoma. In: WHO Classification of Tumours Editorial Board. Head and neck tumours (WHO classification of tumours series), 202; 5.
LIPSCOMB J, et al. Comparing cancer care, outcomes, and costs across health systems: charting the course. J Natl Cancer Inst Monogr. 2013; 46: 124–130.
MACIEL CTV, et al. Análise da qualidade de vida dos pacientes com câncer de laringe em hospital de referência na região Sudeste do Brasil. Rev CEFAC. 2013; 15: 932-940.
MAIN BG. Surgical management of head and neck cancers: implications for dental practitioners. Br Dent J. 2022; 233: 731-736.
MARTINS JDN, et al. Perfil de pacientes com câncer de laringe atendido nos hospitais de alta complexidade oncológica no Pará na série temporal 2000-2017. Res Soc Dev. 2021; 10: 1-10.
Marziliano A, et al. Alcohol‐related head and neck cancer: Summary of the literature. Head neck. 2020; 42: 732-738.
NOCINI R, et al. Updates on larynx cancer epidemiology. Chin J Cancer Res. 2020; 32: 18-25.
OBID R, et al. The treatment of laryngeal cancer. Oral Maxillofac Surg Clin North Am. 2019; 31: 1-11.
OLIVEIRA NPD, et al. Regional and gender differences in laryngeal cancer mortality: trends and predictions until 2030 in Brazil. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122: 547-554.
PANDIT S e SAPKOTA S. Laryngeal Cancer. In: Mallick, S., Rath, G., Benson, R. Practical Radiation Oncology, 1ª ed. Springer, Singapore. 2019; 978-981.
PEZZUTO F, et al. Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies. Oncology. 2015; 89: 125–136.
PINKIEWICZ M, et al. Human Papillomavirus-Associated Head and Neck Cancers. Where are We Now? A Systematic Review. Cancer Manag Res., 2022; 14: 3313-3324.
PURKAYASTHA M, et al. Trends of oral cavity, oropharyngeal and laryngeal cancer incidence in Scotland (1975–2012) – A socioeconomic perspective. Oral Oncol. 2016; 61: 70-75.
SANTANA BWJ, et al. Incidência e características clínicopatológicas do câncer de boca. Revista Eletrônica Acervo Saúde, 2024; 24(2): 14782.
RUDOLPH E, et al. Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis. Eur Arch Otorhinolaryngol. 2011; 268: 165-179.
SIEGEL RL, et al. Cancer statistics, 2019. CA Cancer J Clin., 2019; 66: 7-30.
SILVA IA, et al. Caracterização dos Microrganismos Presentes na Cavidade Oral e Orofaringe de Pacientes Acometidos pelo Câncer de Cabeça e Pescoço Atendidos em um Centro Odontológico Localizado no Agreste Pernambucano: Estudo Piloto. Archives of health investigation, 2023; 12(3): 405–413.
SILVA IA, et al. Impacto do Tratamento Antineoplásico na Microbiota da Cavidade Oral e Orofaríngea de Pacientes Acometidos pelo Câncer de Cabeça e Pescoço: Revisão Sistemática. Rev. Bras. Cancerol., 2022; 68(1): 161581.
SUNG H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin., 2021; 71: 209-249.
THOMAZ EBAF, et al. Oral primary care: an analysis of its impact on the incidence and mortality rates of oral Cancer. BMC Cancer, 2017; 17: 1-11.
WORLD HEALTH ORGANIZATION (WHO). Global Health Estimates 2020: Deaths by Cause, Age, Sex, by country and by Region, 2000-2019. WHO, 2020. Disponível em: https ://www.who.int/data/stories/leading-causes-of-death-and-disability-2000-2019-a-visual-summary. Acessado em: 4 de abril de 2024.